South Africa Halts Oxford Vaccine Over New Covid 19 Strain

South Africa has put its roll-out of the Oxford-Astrazeneca vaccine on hold after a study showed “disappointing” results against its new Covid variant.

Scientists say the strain accounts for 90% of new Covid cases in South Africa.

The study, involving around 2,000 people, found the vaccine offered “minimal protection” against mild and moderate cases of covid-19.

Speaking at an online news conference on Sunday, South African Health Minister, Zweli Mkhize said his government would wait for further advice on how best to proceed with the Oxford-Astrazeneca vaccine in light of the findings.

In the meantime, he said, the government will offer vaccines produced by Johnson & Johnson and Pfizer in the coming weeks.

YOU CAN ALSO READ: *South Africa Covid Infections Passes One Million As The Virus Spreads

DOWNLOAD THE ROCKCITYFM APP AND LISTEN LIVE

Please subscribe to our newsletter

CONTACT US

Do you have any request or enquiry? Do not hesitate to send us an email and we'll get back to you, asap.

Sending

©2021 RockcityFM The Voice of the People

Need Help? Chat with us
or

Log in with your credentials

or    

Forgot your details?

or

Create Account